GLG News by Refractive Surgeons (US)

The light adjustable lens is a lens implant that is placed in the eye like a tradition intraocular lens during cataract surgery.  The unique difference is that it can be treated with a special light after surgical implant (weeks to months later) to correct any residual refractive errors or to fine...

This was a retrospective clinical study of 21 eyes from 12 patients who identified themselves as being dissatisfied with their visual acuity and were interested either in initial or enhancement refractive surgery in order to improve their acuity. Uncorrected visual acuity was documented in each eye....

With the recent trends of presbyopic correction , Bausch and Lomb has now entered the arena.

I HAVE BEEN PRODICTING THAT A MAJOR PLAYER WOULD BUY EYEONICS SINCE I FIRST STARTED PLACING THE CRYSTALENS IN MY PATIENTS. THE LENS WORKS BUT NEEDED A PRO AT MARKETING. B& L WILL BENIFIT FROM THIS BUY.

MOST TEACHING HOSPITALS LOOK DOWN THEIR ACADEMIC NOSE AT ANYTHING COMMERICAL. THESE SAME SCHOOLS DON'T TEACH DOCTORS HOW TO SURVIVE MUCH LESS SUCEED IN THE PRIVATE SECTOR.

As ophthalmologists, we have been waiting for development of a useful telescopic intraocular lens implant for over 17 years. These lenses have been in FDA trials for years, but never brought to market because of numerous problems with them. A viable telescopic lens implant would give us something to...

The market for eye drops for the treatment of open angle glaucoma is huge. Profit potential for pharmaceutical companies, however, is limited by the time period that they are afforded patent protection. Combigan, the just approved brimonidine/timolol combination therapy, affords Allergan new patent...

In the two weeks since Genetech made its announcement that it would limit the availability of Avastin to ophthalmologists for use in treating wet macular degeneration the outcry from patients, ophthalmologists, politicians, and the American Academy of OPhthalmology has been so great that Genetech is...

IOL technology has improved dramatically over the past decade.  However, the current multifocal/accommodating lenses (i.e., ReSTOR, ReZoom, and Crystalens) each have their own strengths and weaknesses.  The topic of matching or mixing lenses has therefore become very important.

The American Academy of Ophthalmology said the recent decision by Genentech to limit availability of Avastin (bevacizumab) to compounding pharmacies could have a significant negative impact on the care of patients with age-related macular degeneration [AMD]. Dr. Charles Wilkinson, president of the AAO,...